Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_32521 | 203 | 4.23 | Mlig455_040932 | Neo: - Age: Down-Down-Up Region-enriched R8: 3.877/0.00012 |
Mlig455_040932 {REF} {Length: 1862} {RNA1310_21335.1} {RNA815_57481} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 2.822 | 2.502 | 0.11568 | 0.70298 | |
RegionR2 | 3.007 | 2.502 | 0.00004 | 0.00212 | |
RegionR3 | -0.244 | 2.502 | 0.71590 | 1.00000 | |
RegionR4 | -1.733 | 2.502 | 0.99435 | 1.00000 | |
RegionR5 | -2.929 | 2.502 | 0.99958 | 1.00000 | |
RegionR6 | -5.758 | 2.502 | 0.00004 | 0.00369 | |
RegionR7 | 0.96 | 2.502 | 0.22339 | 0.84488 | |
RegionR8 | 3.877 | 2.502 | 0.00000 | 0.00012 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -6.671 | 2.502 | 0.18096 | 0.92306 | |
RegenerationR2 | -0.496 | 2.502 | 0.29029 | 0.73347 | |
RegenerationR3 | 0.877 | 2.502 | 0.23747 | 0.67184 | |
RegenerationR4 | 0.619 | 2.502 | 0.46985 | 0.85361 | |
RegenerationR5 | 0.574 | 2.502 | 0.55786 | 0.88995 | |
RegenerationR6 | 3.41 | 2.502 | 0.05641 | 0.29810 | |
RegenerationBL | 2.109 | 2.502 | 0.01763 | 0.14202 | |
RegenerationTP | -0.808 | 2.502 | 0.33393 | 0.77807 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_32521 | 203 | 4.23 | Mlig455_040932 | Neo: - Age: Down-Down-Up Region-enriched R8: 3.877/0.00012 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_040932 {REF} {Length: 1862} {RNA1310_21335.1} {RNA815_57481} | |
2. | MligTC455_21665 | 1283 | 26.74 | Mlig455_000443, Mlig455_000504 | Neo: - Age: logFC(26M/2M)=-0.231 Region-specific R2: 3.326 Region-enriched R2: 2.174/0.00141 |
PPP3R1 | 3.588 | - | - | 0.875 | 0.813 | 0.972 | 0.928 | Mlig455_000443 {REF} {Length: 1489} {Pfam: EF hand [PF00036.34, score=92.6]; EF-hand domain pair [PF13499.8, score=86.6]; EF-hand domain [PF13405.8, score=74.3]; EF hand [PF13202.8, score=72.6]; EF-hand domain pair [PF13833.8, score=65.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.2]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]; EF-hand domain [PF14658.8, score=21.7]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=289, Expect=5e-101]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=289, Expect=3e-101]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=282, Expect=1e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=272, Expect=7e-95]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=281, Expect=1e-98]} {RNA1509_14613, RNA1509_39549} {RNA1310_16848.2, RNA1509_14613, RNA1509_39549} {RNA1509_14613, RNA1509_39549, RNA815_6272} Mlig455_000504 {REF} {Length: 1689} {Pfam: EF hand [PF00036.34, score=90.0]; EF-hand domain pair [PF13499.8, score=84.5]; EF-hand domain [PF13405.8, score=71.9]; EF hand [PF13202.8, score=69.8]; EF-hand domain pair [PF13833.8, score=63.4]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=28.7]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=25.4]; EF-hand domain [PF14658.8, score=19.6]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=290, Expect=2e-100]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=290, Expect=1e-100]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=283, Expect=4e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=274, Expect=3e-94]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=283, Expect=3e-98]} {RNA1509_39549} {RNA1310_16848.2} {RNA815_6272} |
3. | MligTC455_22501 | 73 | 1.51 | Mlig455_036417 | Neo: - |
SLC6A4 | 3.522 | 0.961 | - | 0.919 | 0.881 | 0.761 | - | Mlig455_036417 {REF} {Length: 3681} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=681.8]} {Human: ENSG00000108576, SLC6A4, solute carrier family 6 member 4, [RH, Score=610, Expect=0.0]} {Mouse: ENSMUSG00000020838, Slc6a4, solute carrier family 6 (neurotransmitter transporter, serotonin), member 4, [RH, Score=599, Expect=0.0]} {Dmel: FBgn0010414, SerT, Serotonin transporter, [RH, Score=631, Expect=0.0]} {Celegans: WBGene00003387, mod-5, Transporter, [RH, Score=559, Expect=0.0]} {Smed: dd_Smed_v6_12700_0_1, dd_Smed_v6_12700_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_33614} {RNA1310_10815, RNA1509_33614} {RNA1509_33614, RNA815_8003} |
4. | MligTC455_22502 | 209 | 4.36 | Mlig455_003008, Mlig455_054590 | Neo: - Age: Up-Down-Down |
SLC6A4 | 3.52 | 0.950 | - | 0.915 | 0.880 | 0.775 | - | Mlig455_003008 {REF} {Length: 3661} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=681.8]} {Human: ENSG00000108576, SLC6A4, solute carrier family 6 member 4, [RH, Score=610, Expect=0.0]} {Mouse: ENSMUSG00000020838, Slc6a4, solute carrier family 6 (neurotransmitter transporter, serotonin), member 4, [RH, Score=599, Expect=0.0]} {Dmel: FBgn0010414, SerT, Serotonin transporter, [RH, Score=631, Expect=0.0]} {Celegans: WBGene00003387, mod-5, Transporter, [RH, Score=559, Expect=0.0]} {Smed: dd_Smed_v6_12700_0_1, dd_Smed_v6_12700_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_33614} {RNA1310_10815} {RNA815_8003} Mlig455_054590 {REF} {Length: 3660} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=387.2]} {Human: ENSG00000108576, SLC6A4, solute carrier family 6 member 4, [Score=345, Expect=6e-114]} {Mouse: ENSMUSG00000020838, Slc6a4, solute carrier family 6 (neurotransmitter transporter, serotonin), member 4, [Score=339, Expect=9e-112]} {Dmel: FBgn0010414, SerT, Serotonin transporter, [Score=336, Expect=6e-111]} {Celegans: WBGene00003387, mod-5, Transporter, [Score=332, Expect=7e-109]} {Smed: dd_Smed_v6_12700_0_1, dd_Smed_v6_12700_0_1, [Score=357, Expect=2e-118]} {RNA1509_33614} {RNA1310_10815} {RNA815_8003} |
5. | MligTC455_33703 | 69 | 1.44 | Mlig455_002442 | Neo: - Age: - |
3.475 | 0.889 | - | 0.865 | - | 0.957 | 0.764 | Mlig455_002442 {REF} {Length: 1320} {NoTransDecoderORF} {RNA1310_44761} {RNA815_22052} | |
6. | MligTC455_52281 | 122 | 2.54 | Mlig455_054688 | Neo: - Age: - Region-enriched R2: 3.102/0.03108 |
3.465 | 0.980 | 0.768 | 0.881 | - | - | 0.836 | Mlig455_054688 {REF} {Length: 852} {RNA1509_17653} {RNA1310_86153} {RNA815_32362} | |
7. | MligTC455_18988 | 84 | 1.76 | Mlig455_063835 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.612 Region-enriched R4: 4.537/0.00889 |
SYN3 | 3.387 | 0.971 | - | - | 0.865 | 0.747 | 0.804 | Mlig455_063835 {REF} {Length: 2341} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=194.6]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.0]} {Human: ENSG00000185666, SYN3, synapsin III, [Score=188, Expect=4e-53]; ENSG00000157152, SYN2, synapsin II, [Score=185, Expect=2e-55]; ENSG00000008056, SYN1, synapsin I, [Score=184, Expect=8e-51]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [Score=191, Expect=4e-54]; ENSMUSG00000037217, Syn1, synapsin I, [Score=186, Expect=2e-51]; ENSMUSG00000009394, Syn2, synapsin II, [Score=185, Expect=7e-53]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=159, Expect=7e-43]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=115, Expect=3e-28]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [RH, Score=177, Expect=2e-51]} {RNA1310_16093.1} {RNA815_2386} |
8. | MligTC455_40341 | 106 | 2.2 | Mlig455_060207, Mlig455_070456 | Neo: - Age: Down-Down-Up Region-enriched R2: 6.703/0.00648 |
NPY2R | 3.319 | - | - | 0.960 | 0.849 | 0.713 | 0.797 | Mlig455_060207 {REF} {Length: 3062} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=177.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=178, Expect=9e-51]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=176, Expect=3e-50]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=176, Expect=1e-49]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [Score=245, Expect=4e-74]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=215, Expect=5e-65]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=313, Expect=2e-103]} {RNA1310_18147.1} {RNA815_7986} Mlig455_070456 {REF} {Length: 3569} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=176.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.3]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=177, Expect=8e-50]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=175, Expect=3e-49]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=174, Expect=2e-48]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [RH, Score=166, Expect=2e-44]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=215, Expect=4e-64]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=315, Expect=8e-103]} {RNA1310_18147.1} {RNA815_7986} |
9. | MligTC455_48302 | 45 | 0.93 | Mlig455_056275 | Neo: - Age: - |
CHRNA7 | 3.298 | - | - | 0.777 | 0.777 | 0.981 | 0.763 | Mlig455_056275 {REF} {Length: 3506} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=176.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=131.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=255, Expect=4e-76]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=251, Expect=5e-75]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=250, Expect=2e-74]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=245, Expect=6e-73]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=237, Expect=7e-70]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=234, Expect=6e-69]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=271, Expect=1e-82]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=254, Expect=1e-76]} {Smed: dd_Smed_v6_18201_0_1, dd_Smed_v6_18201_0_1, [Score=471, Expect=8e-158]} {RNA1509_49660} {RNA1310_35095} {RNA815_30373} |
10. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
2.793 | 0.907 | - | 0.976 | - | 0.910 | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
11. | MligTC455_16438 | 37 | 0.77 | Mlig455_062255 | Neo: - Age: - |
STUM | 2.75 | 0.974 | - | - | - | 0.910 | 0.866 | Mlig455_062255 {REF} {Length: 2394} {Pfam: Ectodermal ciliogenesis protein [PF15795.7, score=81.0]} {Human: ENSG00000203685, STUM, stum, mechanosensory transduction mediator homolog, [RH, Score=51.2, Expect=7e-08]} {Mouse: ENSMUSG00000053963, Stum, mechanosensory transduction mediator, [RH, Score=50.4, Expect=1e-07]} {Dmel: FBgn0050263, stum, stumble, [Score=50.8, Expect=4e-07]} {RNA1310_24095} {RNA815_31266} |
12. | MligTC455_14149 | 226 | 4.71 | Mlig455_017664, Mlig455_017690, Mlig455_017741 | Neo: - Age: Up-Down-Down |
SLC6A5 | 2.748 | 0.958 | - | - | 0.882 | 0.908 | - | Mlig455_017664 {REF} {Length: 2439} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=584.2]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=510, Expect=5e-171]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=509, Expect=7e-171]} {Dmel: FBgn0034911, CG5549, [Score=509, Expect=3e-166]} {Celegans: WBGene00004902, snf-3, Sodium- and chloride-dependent betaine transporter, [Score=373, Expect=1e-120]} {Smed: dd_Smed_v6_10458_0_2, dd_Smed_v6_10458_0_2, [Score=500, Expect=2e-169]} {RNA1509_52349} {RNA1310_8571.2} {RNA815_10787} Mlig455_017690 {REF} {Length: 2567} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=581.8]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=513, Expect=4e-172]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=512, Expect=8e-172]} {Dmel: FBgn0034911, CG5549, [Score=520, Expect=2e-170]} {Celegans: WBGene00004902, snf-3, Sodium- and chloride-dependent betaine transporter, [Score=371, Expect=5e-120]} {Smed: dd_Smed_v6_10458_0_1, dd_Smed_v6_10458_0_1, [Score=502, Expect=1e-169]} {RNA1509_52349} {RNA1310_8571.1, RNA1509_52349} {RNA1509_52349, RNA815_10787} Mlig455_017741 {REF} {Length: 2497} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=582.2]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=518, Expect=1e-173]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=516, Expect=3e-173]} {Dmel: FBgn0034911, CG5549, [Score=519, Expect=8e-170]} {Celegans: WBGene00004902, snf-3, Sodium- and chloride-dependent betaine transporter, [Score=371, Expect=1e-119]} {Smed: dd_Smed_v6_10458_0_1, dd_Smed_v6_10458_0_1, [Score=511, Expect=8e-173]} {RNA1509_52349} {RNA1310_8571.1} {RNA815_10787} |
13. | MligTC455_51780 | 138 | 2.88 | Mlig455_046894 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.174/0.00338 |
PNPO | 2.746 | 0.967 | - | 0.889 | - | 0.890 | - | Mlig455_046894 {REF} {Length: 2339} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=78.4]; Pyridoxine 5'-phosphate oxidase C-terminal dimerisation region [PF10590.11, score=69.2]; Pyridoxamine 5'-phosphate oxidase [PF12766.9, score=22.3]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=182, Expect=7e-57]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [RH, Score=184, Expect=1e-57]} {Dmel: FBgn0051472, sgll, sugarlethal, [Score=168, Expect=6e-52]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [RH, Score=200, Expect=1e-64]} {Smed: dd_Smed_v6_5086_0_1, dd_Smed_v6_5086_0_1, [RH, Score=177, Expect=2e-55]} {RNA1509_54079} {RNA1310_31564.1, RNA1509_54079} {RNA1509_54079, RNA815_34098} |
14. | MligTC455_12525 | 11 | 0.23 | Mlig455_067862 | Neo: - Age: - |
2.741 | - | - | 0.969 | 0.881 | 0.891 | - | Mlig455_067862 {REF} {Length: 1730} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=44.0]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=18.1]} {Smed: dd_Smed_v6_13661_0_2, dd_Smed_v6_13661_0_2, [Score=80.9, Expect=3e-17]} {RNA1509_20770} {RNA1310_58410} {RNA815_35907} | |
15. | MligTC455_26519 | 183 | 3.82 | Mlig455_030983, Mlig455_069440 | Neo: - Age: - |
2.732 | - | - | 0.954 | - | 0.849 | 0.929 | Mlig455_030983 {REF} {Length: 688} {RNA1509_12904} {RNA1310_62229} {RNA815_56172} Mlig455_069440 {REF} {Length: 1096} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=54.9]} {RNA1509_35362} {RNA1310_21423.2} {RNA815_13686} |
|
16. | MligTC455_33772 | 104 | 2.17 | Mlig455_016493 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.862/0.00025 |
2.723 | - | - | 0.972 | - | 0.897 | 0.854 | Mlig455_016493 {REF} {Length: 883} {RNA1310_43848} {RNA815_55624} | |
17. | MligTC455_40199 | 64 | 1.33 | Mlig455_026444, Mlig455_026477 | Neo: - Age: - |
ASIC4 | 2.717 | - | - | 0.984 | 0.881 | 0.852 | - | Mlig455_026444 {REF} {Length: 2570} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=204.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=57.4, Expect=7e-08]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=53.9, Expect=5e-07]; ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=52.4, Expect=1e-06]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=69.7, Expect=5e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=119, Expect=6e-28]} {RNA1310_21223} {RNA815_27174} Mlig455_026477 {REF} {Length: 2402} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=160.5]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=57.0, Expect=8e-08]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=53.9, Expect=5e-07]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=69.3, Expect=5e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=93.6, Expect=9e-20]} {RNA1310_21223} {RNA815_27174} |
18. | MligTC455_31464 | 20 | 0.41 | Mlig455_057157 | Neo: - Age: - |
2.716 | - | - | 0.892 | 0.873 | 0.951 | - | Mlig455_057157 {REF} {Length: 1285} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=38.2]} {Smed: dd_Smed_v6_13824_0_1, dd_Smed_v6_13824_0_1, [RH, Score=47.0, Expect=2e-07]} {RNA1509_6604} {RNA1310_12860.1} {RNA815_6128.1} | |
19. | MligTC455_27678 | 355 | 7.4 | Mlig455_070610 | Neo: - Age: - Region-specific R2: 4.724 Region-enriched R2: 3.766/0.00062 |
2.711 | 0.831 | - | 0.973 | - | 0.907 | - | Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024} | |
20. | MligTC455_15890 | 18 | 0.38 | Mlig455_059636 | Neo: - Age: - |
CD209 | 2.693 | - | - | 0.951 | 0.844 | 0.898 | - | Mlig455_059636 {REF} {Length: 1223} {Pfam: Lectin C-type domain [PF00059.23, score=29.7]} {Human: ENSG00000090659, CD209, CD209 molecule, [Score=49.3, Expect=2e-06]} {Dmel: FBgn0040096, lectin-33A, [Score=48.9, Expect=6e-07]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=64.7, Expect=2e-12]} {RNA1509_20946} {RNA1310_53178} {RNA815_42043} |
21. | MligTC455_45621 | 610 | 12.72 | Mlig455_041531 | Neo: - Age: - Region-specific R2: 5.645 Region-enriched R2: 4.169/0.00001 |
2.664 | - | - | 0.955 | 0.806 | 0.903 | - | Mlig455_041531 {REF} {Length: 1004} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982, RNA1509_8166} {RNA1310_46295, RNA1509_31982, RNA1509_8166} {RNA1509_31982, RNA1509_8166, RNA815_23543} | |
22. | MligTC455_47918 | 119 | 2.48 | Mlig455_006053 | Neo: - Age: Down-Down-Up |
PODNL1 | 2.652 | - | - | 0.860 | - | 0.955 | 0.837 | Mlig455_006053 {REF} {Length: 2760} {Pfam: Leucine rich repeat [PF13855.8, score=191.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=113.3]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=36.9]; Leucine Rich Repeat [PF00560.35, score=35.8]; Leucine Rich repeat [PF13516.8, score=34.6]; Leucine-rich repeat [PF14580.8, score=29.3]; Leucine rich repeat C-terminal domain [PF01463.26, score=21.8]} {Human: ENSG00000132000, PODNL1, podocan like 1, [Score=90.1, Expect=4e-18]; ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=87.8, Expect=3e-17]; ENSG00000205213, LGR4, leucine rich repeat containing G protein-coupled receptor 4, [Score=87.8, Expect=4e-17]; ENSG00000137507, LRRC32, leucine rich repeat containing 32, [Score=87.4, Expect=4e-17]} {Mouse: ENSMUSG00000063765, Chadl, chondroadherin-like, [Score=96.3, Expect=5e-20]; ENSMUSG00000052316, Lrrc15, leucine rich repeat containing 15, [Score=92.4, Expect=7e-19]; ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [Score=92.0, Expect=8e-19]} {Dmel: FBgn0261269, conv, convoluted, [Score=109, Expect=4e-24]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [Score=92.0, Expect=9e-19]} {Smed: dd_Smed_v6_6669_0_1, dd_Smed_v6_6669_0_1, [Score=92.8, Expect=3e-19]} {RNA1509_47596} {RNA1310_6895, RNA1509_47596} {RNA1509_47596, RNA815_5082} |
23. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 2.648 | - | - | 0.903 | 0.783 | 0.962 | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
24. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
2.647 | - | - | 0.967 | 0.782 | 0.898 | - | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
25. | MligTC455_23825 | 29 | 0.6 | Mlig455_002166, Mlig455_002310 | Neo: - Age: Down-Up-Down |
NOL4 | 2.643 | - | - | 0.978 | - | 0.898 | 0.767 | Mlig455_002166 {REF} {Length: 3243} {Human: ENSG00000101746, NOL4, nucleolar protein 4, [RH, Score=135, Expect=9e-35]} {Mouse: ENSMUSG00000041923, Nol4, nucleolar protein 4, [RH, Score=136, Expect=1e-34]} {Dmel: FBgn0283651, CG46301, [RH, Score=140, Expect=4e-35]} {Smed: dd_Smed_v6_10255_0_1, dd_Smed_v6_10255_0_1, [RH, Score=82.4, Expect=6e-17]} {RNA1509_41791} {RNA1310_36173.1} {RNA815_37287} Mlig455_002310 {REF} {Length: 2667} {Human: ENSG00000101746, NOL4, nucleolar protein 4, [RH, Score=135, Expect=1e-34]} {Mouse: ENSMUSG00000041923, Nol4, nucleolar protein 4, [RH, Score=136, Expect=1e-34]} {Dmel: FBgn0283651, CG46301, [RH, Score=140, Expect=4e-35]} {Smed: dd_Smed_v6_10255_0_1, dd_Smed_v6_10255_0_1, [RH, Score=82.4, Expect=6e-17]} {RNA1509_41791} {RNA1310_36173.1} |
26. | MligTC455_09748 | 23 | 0.48 | Mlig455_021244 | Neo: - Age: - |
2.641 | 0.982 | - | 0.863 | 0.796 | - | - | Mlig455_021244 {REF} {Length: 1248} {RNA1310_73799} {RNA815_52728} | |
27. | MligTC455_17089 | 173 | 3.6 | Mlig455_022974 | Neo: - Age: - Region-enriched R4: 2.568/0.01700 |
2.628 | 0.955 | - | - | 0.809 | 0.864 | - | Mlig455_022974 {REF} {Length: 1697} {RNA1509_56619} {RNA1310_21133.1} {RNA815_8631.1} | |
28. | MligTC455_35365 | 14 | 0.29 | Mlig455_051974 | Neo: - Age: - |
NPFFR2 | 2.624 | - | - | 0.979 | 0.815 | 0.830 | - | Mlig455_051974 {REF} {Length: 1412} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=184.8]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=44.6]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=172, Expect=6e-49]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=162, Expect=3e-45]; ENSMUSG00000028778, Hcrtr1, hypocretin (orexin) receptor 1, [Score=155, Expect=7e-43]} {Dmel: FBgn0004842, RYa-R, RYamide receptor, [Score=168, Expect=3e-47]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [RH, Score=157, Expect=9e-44]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=265, Expect=5e-85]} {RNA1310_123208} {RNA815_46307} |
29. | MligTC455_52527 | 28 | 0.58 | Mlig455_025836 | Neo: - Age: - |
FLVCR2 | 2.624 | - | - | 0.978 | - | 0.827 | 0.819 | Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234} |
30. | MligTC455_40051 | 36 | 0.76 | Mlig455_025990 | Neo: - Age: logFC(26M/2M)=-0.633 |
PRKCE | 2.606 | - | - | 0.966 | 0.790 | 0.850 | - | Mlig455_025990 {REF} {Length: 2622} {Pfam: Protein kinase domain [PF00069.27, score=102.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=69.5]; Kinase-like [PF14531.8, score=19.5]} {Human: ENSG00000171132, PRKCE, protein kinase C epsilon, [Score=84.3, Expect=1e-16]} {Mouse: ENSMUSG00000045038, Prkce, protein kinase C, epsilon, [Score=82.0, Expect=5e-16]} {Dmel: FBgn0283472, S6k, Ribosomal protein S6 kinase, [Score=79.0, Expect=2e-15]} {Celegans: WBGene00009793, pkn-1, Protein Kinase N (PKN) homolog, [Score=73.2, Expect=2e-13]} {Smed: dd_Smed_v6_8010_0_1, dd_Smed_v6_8010_0_1, [Score=77.8, Expect=4e-15]} {RNA1509_36146} {RNA1310_24732} {RNA815_64704} |
31. | MligTC455_42136 | 34 | 0.7 | Mlig455_024685, Mlig455_024710, Mlig455_044068 | Neo: - Age: - |
2.605 | - | - | 0.903 | - | 0.958 | 0.744 | Mlig455_024685 {REF} {Length: 3505} {Pfam: Peptidase family M13 [PF05649.15, score=22.4]} {RNA1310_55586} {RNA815_38189} Mlig455_024710 {REF} {Length: 3484} {RNA1310_55586} {RNA815_38189} Mlig455_044068 {REF} {Length: 2578} {Pfam: Peptidase family M13 [PF05649.15, score=26.4]} |
|
32. | MligTC455_19758 | 53 | 1.1 | Mlig455_002464 | Neo: - Age: - Region-enriched R2: 6.578/0.02863 |
2.592 | - | - | 0.986 | 0.830 | 0.776 | - | Mlig455_002464 {REF} {Length: 2549} {RNA1310_38437} {RNA815_40458} | |
33. | MligTC455_16329 | 1019 | 21.23 | Mlig455_007993 | Neo: - Age: - Region-specific R2: 3.685 Region-enriched R2: 3.576/0.00000 |
2.591 | - | - | 0.961 | - | 0.902 | 0.728 | Mlig455_007993 {REF} {Length: 635} {RNA1509_22236} {RNA1310_84275, RNA1509_22236} {RNA1509_22236, RNA815_43046} | |
34. | MligTC455_41993 | 177 | 3.68 | Mlig455_058555 | Neo: - Age: - |
SLC18A2 | 2.581 | 0.981 | - | - | 0.831 | 0.769 | - | Mlig455_058555 {REF} {Length: 2488} {Pfam: Major Facilitator Superfamily [PF07690.18, score=160.2]} {Human: ENSG00000165646, SLC18A2, solute carrier family 18 member A2, [RH, Score=505, Expect=4e-173]} {Mouse: ENSMUSG00000025094, Slc18a2, solute carrier family 18 (vesicular monoamine), member 2, [RH, Score=506, Expect=9e-174]} {Dmel: FBgn0260964, Vmat, Vesicular monoamine transporter, [RH, Score=522, Expect=9e-179]} {Celegans: WBGene00000295, cat-1, [RH, Score=478, Expect=1e-162]} {Smed: dd_Smed_v6_16043_0_1, dd_Smed_v6_16043_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_54526} {RNA1310_13917.1} {RNA815_24305} |
35. | MligTC455_34949 | 30 | 0.63 | Mlig455_055437 | Neo: - Age: - |
RIMS1 | 2.576 | - | - | 0.855 | - | 0.985 | 0.736 | Mlig455_055437 {REF} {Length: 5246} {Pfam: C2 domain [PF00168.32, score=104.4]; PDZ domain [PF17820.3, score=39.9]; PDZ domain [PF00595.26, score=32.1]; Piccolo Zn-finger [PF05715.15, score=24.7]; PDZ domain [PF13180.8, score=24.0]; FYVE-type zinc finger [PF02318.18, score=19.4]} {Human: ENSG00000079841, RIMS1, regulating synaptic membrane exocytosis 1, [RH, Score=239, Expect=2e-63]; ENSG00000176406, RIMS2, regulating synaptic membrane exocytosis 2, [RH, Score=238, Expect=2e-63]} {Mouse: ENSMUSG00000037386, Rims2, regulating synaptic membrane exocytosis 2, [RH, Score=241, Expect=3e-64]; ENSMUSG00000111628, Rims1, regulating synaptic membrane exocytosis 1, [RH, Score=240, Expect=1e-66]; ENSMUSG00000041670, Rims1, regulating synaptic membrane exocytosis 1, [RH, Score=240, Expect=1e-66]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [RH, Score=243, Expect=6e-65]} {Celegans: WBGene00006750, unc-10, Rab-3-interacting molecule unc-10, [RH, Score=187, Expect=1e-47]} {Smed: dd_Smed_v6_10734_0_1, dd_Smed_v6_10734_0_1, [RH, Score=281, Expect=6e-80]} {RNA1509_26372} {RNA1310_18417, RNA1509_26372} {RNA1509_26372, RNA815_9566} |
36. | MligTC455_37682 | 225 | 4.68 | Mlig455_022978, Mlig455_023072 | Neo: - Age: Up-Down-Up Region-enriched R7: 2.657/0.03586 |
KCNN2 | 2.575 | 0.976 | - | - | - | 0.843 | 0.756 | Mlig455_022978 {REF} {Length: 4236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.8]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=548, Expect=0.0]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=539, Expect=1e-180]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=549, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=541, Expect=0.0]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=637, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=424, Expect=5e-135]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1, RNA1509_28013} {RNA1509_28013, RNA815_7768} Mlig455_023072 {REF} {Length: 3426} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.0]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=534, Expect=3e-177]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=525, Expect=2e-175]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=536, Expect=1e-178]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=528, Expect=1e-176]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=627, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=410, Expect=8e-130]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_7768} |
37. | MligTC455_22263 | 1046 | 21.79 | Mlig455_034483 | Neo: - Age: - Region-specific R2: 3.299 Region-enriched R2: 2.796/0.00007 |
2.57 | 0.723 | - | 0.970 | - | 0.877 | - | Mlig455_034483 {REF} {Length: 740} {Smed: dd_Smed_v6_4417_0_1, dd_Smed_v6_4417_0_1, [Score=40.8, Expect=1e-05]} {RNA1509_19386, RNA1509_37949} {RNA1310_48041.1, RNA1509_37949} {RNA1509_37949, RNA815_28750} | |
38. | MligTC455_51872 | 25 | 0.51 | Mlig455_002762, Mlig455_063364 | Neo: - Age: - |
2.567 | - | - | 0.818 | 0.779 | - | 0.970 | Mlig455_002762 {REF} {Length: 1093} {RNA1310_80259} {RNA815_47710} Mlig455_063364 {REF} {Length: 1091} {RNA1310_80259} {RNA815_47710} |
|
39. | MligTC455_17235 | 216 | 4.51 | Mlig455_058265 | Neo: - Age: - |
ANO7 | 2.564 | 0.975 | - | 0.817 | - | 0.772 | - | Mlig455_058265 {REF} {Length: 1888} {Pfam: Calcium-activated chloride channel [PF04547.14, score=264.3]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=394, Expect=4e-129]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=392, Expect=9e-130]} {Dmel: FBgn0038721, subdued, [Score=268, Expect=5e-82]} {Celegans: WBGene00013326, anoh-2, Anoctamin, [Score=85.1, Expect=9e-18]} {Smed: dd_Smed_v6_19189_0_1, dd_Smed_v6_19189_0_1, [Score=476, Expect=2e-164]} {RNA1509_15570} {RNA1310_7822} {RNA815_20477} |
40. | MligTC455_21033 | 1129 | 23.52 | Mlig455_010672 | Neo: - Age: logFC(26M/2M)=0.356 Region-specific R2: 3.326 Region-enriched R2: 2.739/0.00000 Regeneration-downregulated R2: -1.967 Regeneration-depleted R2: -1.967 |
2.557 | - | - | 0.787 | - | 0.819 | 0.951 | Mlig455_010672 {REF} {Length: 829} {RNA1509_30331, RNA1509_45731} {RNA1310_60944, RNA1509_30331, RNA1509_45731} {RNA1509_30331, RNA1509_45731, RNA815_27381.1} | |
41. | MligTC455_53128 | 27 | 0.57 | Mlig455_070169 | Neo: - Age: - |
ATL1 | 2.552 | - | - | 0.956 | 0.710 | 0.886 | - | Mlig455_070169 {REF} {Length: 1728} {Pfam: Guanylate-binding protein, N-terminal domain [PF02263.21, score=60.7]} {Human: ENSG00000198513, ATL1, atlastin GTPase 1, [Score=127, Expect=5e-31]; ENSG00000119787, ATL2, atlastin GTPase 2, [Score=121, Expect=1e-29]} {Mouse: ENSMUSG00000021066, Atl1, atlastin GTPase 1, [Score=125, Expect=1e-30]; ENSMUSG00000059811, Atl2, atlastin GTPase 2, [Score=122, Expect=5e-30]} {Dmel: FBgn0039213, atl, atlastin, [Score=117, Expect=6e-28]} {Celegans: WBGene00012763, atln-2, ATLastiN (Endoplasmic reticulum GTPase) related, [Score=115, Expect=1e-28]} {Smed: dd_Smed_v6_4450_0_1, dd_Smed_v6_4450_0_1, [Score=97.8, Expect=1e-21]} {RNA1509_32178} {RNA1310_34862} {RNA815_28130} |
42. | MligTC455_38227 | 131 | 2.73 | Mlig455_049364 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.468/0.02435 |
2.511 | 0.960 | - | 0.802 | - | 0.749 | - | Mlig455_049364 {REF} {Length: 726} {RNA1509_22173} {RNA1310_65747} {RNA815_15489} | |
43. | MligTC455_46566 | 167 | 3.47 | Mlig455_030556 | Neo: - Age: - Region-enriched R2: 2.352/0.01128 |
2.493 | 0.960 | - | 0.701 | - | 0.832 | - | Mlig455_030556 {REF} {Length: 2003} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=86.7, Expect=8e-19]} {RNA1509_3114} {RNA1310_34234} {RNA815_19594} | |
44. | MligTC455_23101 | 397 | 8.28 | Mlig455_048080 | Neo: - Age: - Region-enriched R2: 3.122/0.00807 |
2.463 | - | - | 0.775 | 0.738 | 0.950 | - | Mlig455_048080 {REF} {Length: 721} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452, RNA1509_16955} {RNA1509_16955, RNA815_4585} | |
45. | MligTC455_40263 | 3158 | 65.79 | Mlig455_001952 | Neo: - Age: - Region-enriched R2: 1.169/0.00614 Regeneration-depleted R6: -2.248 |
2.462 | - | - | 0.774 | - | 0.728 | 0.960 | Mlig455_001952 {REF} {Length: 1514} {Pfam: Sleepless protein [PF17064.7, score=24.1]} {RNA1509_37822, RNA1509_45625, RNA1509_8377} {RNA1310_29492, RNA1509_37822, RNA1509_45625, RNA1509_8377} {RNA1509_37822, RNA1509_45625, RNA1509_8377, RNA815_14881} | |
46. | MligTC455_51536 | 78 | 1.62 | Mlig455_040699 | Neo: - Age: - |
2.461 | 0.993 | - | 0.754 | - | 0.714 | - | Mlig455_040699 {REF} {Length: 2015} {RNA1310_34295.1} {RNA815_22630} | |
47. | MligTC455_18224 | 166 | 3.45 | Mlig455_005350 | Neo: - Age: - |
KCNA2 | 2.458 | 0.975 | - | - | 0.715 | 0.768 | - | Mlig455_005350 {REF} {Length: 3033} {Pfam: Ion transport protein [PF00520.33, score=167.1]; BTB/POZ domain [PF02214.24, score=98.0]; Ion channel [PF07885.18, score=49.0]} {Human: ENSG00000177301, KCNA2, potassium voltage-gated channel subfamily A member 2, [RH, Score=605, Expect=0.0]; ENSG00000111262, KCNA1, potassium voltage-gated channel subfamily A member 1, [RH, Score=601, Expect=0.0]; ENSG00000177272, KCNA3, potassium voltage-gated channel subfamily A member 3, [RH, Score=600, Expect=0.0]} {Mouse: ENSMUSG00000040724, Kcna2, potassium voltage-gated channel, shaker-related subfamily, member 2, [RH, Score=607, Expect=0.0]; ENSMUSG00000047976, Kcna1, potassium voltage-gated channel, shaker-related subfamily, member 1, [RH, Score=600, Expect=0.0]; ENSMUSG00000047959, Kcna3, potassium voltage-gated channel, shaker-related subfamily, member 3, [RH, Score=598, Expect=0.0]} {Dmel: FBgn0003380, Sh, Shaker, [RH, Score=629, Expect=0.0]} {Celegans: WBGene00014261, shk-1, Potassium voltage-gated channel protein shk-1, [RH, Score=380, Expect=3e-124]} {Smed: dd_Smed_v6_15425_0_1, dd_Smed_v6_15425_0_1, [RH, Score=704, Expect=0.0]} {RNA1509_33947} {RNA1310_1447.1} {RNA815_7992} |
48. | MligTC455_25556 | 160 | 3.33 | Mlig455_041382 | Neo: - Age: - Region-specific R2: 5.503 Region-enriched R2: 4.706/0.00082 |
2.431 | - | - | 0.972 | - | 0.711 | 0.748 | Mlig455_041382 {REF} {Length: 1197} {RNA1509_55439} {RNA1310_65119, RNA1509_55439} {RNA1509_55439, RNA815_36098.2} | |
49. | MligTC455_48230 | 218 | 4.55 | Mlig455_025904 | Neo: - Age: - |
2.414 | 0.959 | - | 0.752 | - | 0.703 | - | Mlig455_025904 {REF} {Length: 3803} {Pfam: Domain of unknown function (DUF4139) [PF13598.8, score=147.7]; N-terminal domain of unknown function (DUF4140) [PF13600.8, score=63.8]} {Celegans: WBGene00016877, C52D10.3, [Score=253, Expect=5e-74]} {Smed: dd_Smed_v6_3629_0_1, dd_Smed_v6_3629_0_1, [RH, Score=449, Expect=7e-148]} {RNA1509_25634} {RNA1310_6356.1} {RNA815_11616} | |
50. | MligTC455_48520 | 46 | 0.96 | Mlig455_004433 | Neo: - Age: - |
1.933 | 0.978 | - | 0.955 | - | - | - | Mlig455_004433 {REF} {Length: 701} {RNA1310_56623} {RNA815_27009} | |
51. | MligTC455_17823 | 201 | 4.19 | Mlig455_019410 | Neo: - Age: Down-Up-Up |
1.929 | 0.974 | - | - | - | 0.955 | - | Mlig455_019410 {REF} {Length: 1704} {RNA1310_21496} {RNA815_47261} | |
52. | MligTC455_00245 | 15 | 0.32 | Mlig455_040042 | Neo: - Age: - |
GPR17 | 1.927 | - | - | 0.965 | - | 0.962 | - | Mlig455_040042 {REF} {Length: 1332} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.0]} {Human: ENSG00000144230, GPR17, G protein-coupled receptor 17, [Score=48.9, Expect=6e-06]} {Smed: dd_Smed_v6_61185_0_1, dd_Smed_v6_61185_0_1, [Score=70.9, Expect=1e-14]} {RNA1310_142905} |
53. | MligTC455_26896 | 68 | 1.41 | Mlig455_044263 | Neo: - Age: logFC(26M/2M)=1.950 |
1.918 | - | - | 0.983 | - | - | 0.935 | Mlig455_044263 {REF} {Length: 2369} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_6921} {RNA1310_72140} {RNA815_9260.1} | |
54. | MligTC455_47943 | 83 | 1.73 | Mlig455_018165, Mlig455_069944 | Neo: - |
1.912 | 0.934 | - | 0.978 | - | - | - | Mlig455_018165 {REF} {Length: 2120} {RNA1509_50096} {RNA1310_19543, RNA1509_50096} {RNA1509_50096, RNA815_21860} Mlig455_069944 {REF} {Length: 2117} {RNA1509_50096} {RNA1310_19543} {RNA815_21860} |
|
55. | MligTC455_29261 | 34 | 0.71 | Mlig455_024258 | Neo: - Age: - |
1.908 | - | - | 0.978 | - | 0.930 | - | Mlig455_024258 {REF} {Length: 1171} {RNA1509_25125} {RNA1310_234.1} {RNA815_23.1} | |
56. | MligTC455_46470 | 552 | 11.5 | Mlig455_066293 | Neo: - Age: Down-Down-Up Region-enriched R2: 3.795/0.00284 |
1.903 | - | - | 0.936 | - | 0.967 | - | Mlig455_066293 {REF} {Length: 896} {RNA1509_9692} {RNA1310_57568} {RNA815_29793} | |
57. | MligTC455_49829 | 606 | 12.63 | Mlig455_018528 | Neo: - Age: - Region-enriched R8: 5.323/0.00000 |
1.897 | - | 0.914 | - | - | 0.983 | - | Mlig455_018528 {REF} {Length: 3314} {Pfam: Plectin repeat [PF00681.22, score=39.5]; SH3 domain [PF17902.3, score=22.5]} {Dmel: FBgn0013733, shot, short stop, [Score=57.0, Expect=9e-08]} {Celegans: WBGene00006952, wrt-6, Warthog protein 6 Warthog protein 6 N-product Warthog protein 6 C-product, [Score=51.2, Expect=3e-06]} {RNA1509_40966} {RNA1310_5072.1} {RNA815_12828} | |
58. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 1.895 | 0.935 | - | - | - | 0.960 | - | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
59. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
1.895 | - | - | 0.980 | - | 0.915 | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
60. | MligTC455_50171 | 151 | 3.14 | Mlig455_065462 | Neo: - Age: logFC(26M/2M)=0.548 Region-specific R2: 5.212 Region-enriched R2: 5.063/0.00089 Regeneration-downregulated R2: -2.783 Regeneration-depleted R2: -2.783 |
SCNN1A | 1.895 | 0.935 | - | 0.960 | - | - | - | Mlig455_065462 {REF} {Length: 3905} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=60.1, Expect=9e-09]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=67.0, Expect=5e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=92.8, Expect=1e-19]} {Smed: dd_Smed_v6_16959_0_1, dd_Smed_v6_16959_0_1, [Score=275, Expect=3e-83]} {RNA1509_60030} {RNA1310_56761} {RNA815_31877.1} |
61. | MligTC455_14216 | 241 | 5.03 | Mlig455_044260 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.597/0.00013 |
DBH | 1.892 | - | - | 0.958 | - | 0.934 | - | Mlig455_044260 {REF} {Length: 840} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=26.2]} {Human: ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=70.9, Expect=4e-15]} {Mouse: ENSMUSG00000000889, Dbh, dopamine beta hydroxylase, [Score=72.0, Expect=1e-15]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=64.7, Expect=3e-13]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=52.4, Expect=5e-09]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=65.1, Expect=1e-13]} {RNA1509_17014} {RNA1310_13801} {RNA815_8852} |
62. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
1.89 | - | - | 0.968 | - | 0.922 | - | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
63. | MligTC455_29168 | 95 | 1.99 | Mlig455_001005 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.838/0.04040 |
DNAH5 | 1.887 | 0.976 | - | - | - | 0.911 | - | Mlig455_001005 {REF} {Length: 14882} {Pfam: Dynein heavy chain, N-terminal region 1 [PF08385.14, score=578.4]; Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=466.5]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=431.3]; Dynein heavy chain C-terminal domain [PF18199.3, score=314.7]; P-loop containing dynein motor region D4 [PF12780.9, score=302.4]; ATP-binding dynein motor region [PF12781.9, score=290.8]; P-loop containing dynein motor region [PF12775.9, score=229.7]; Dynein heavy chain AAA lid domain [PF18198.3, score=179.1]; Microtubule-binding stalk of dynein motor [PF12777.9, score=143.2]; Dynein heavy chain region D6 P-loop domain [PF03028.17, score=121.5]; AAA domain (dynein-related subfamily) [PF07728.16, score=75.6]; Dynein heavy chain AAA lid domain [PF17852.3, score=70.7]; AAA+ lid domain [PF17857.3, score=60.9]; AAA ATPase domain [PF13191.8, score=22.0]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.4]; P-loop containing region of AAA domain [PF13555.8, score=20.3]} {Human: ENSG00000039139, DNAH5, dynein axonemal heavy chain 5, [RH, Score=6260, Expect=0.0]} {Mouse: ENSMUSG00000022262, Dnah5, dynein, axonemal, heavy chain 5, [RH, Score=6234, Expect=0.0]} {Dmel: FBgn0037726, CG9492, [RH, Score=5093, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=1290, Expect=0.0]} {Smed: dd_Smed_v6_4569_0_1, dd_Smed_v6_4569_0_1, [RH, Score=6941, Expect=0.0]} {RNA1509_51275} {RNA1310_408, RNA1509_51275} {RNA1509_51275, RNA815_44.1} |
64. | MligTC455_50665 | 48 | 0.99 | Mlig455_032812 | Neo: - Age: - |
1.887 | 0.962 | - | - | - | 0.925 | - | Mlig455_032812 {REF} {Length: 1550} {Pfam: Glycine rich protein [PF12810.9, score=23.7]} {RNA1310_48243.1} {RNA815_30313.2} | |
65. | MligTC455_14043 | 12 | 0.26 | Mlig455_016776 | Neo: - Age: - |
ANKRD63 | 1.882 | - | - | 0.973 | - | 0.909 | - | Mlig455_016776 {REF} {Length: 1715} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=122.1]; Ankyrin repeats (many copies) [PF13637.8, score=70.6]; Ankyrin repeats (many copies) [PF13857.8, score=54.8]; Ankyrin repeat [PF00023.32, score=50.2]; Ankyrin repeat [PF13606.8, score=43.7]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=130, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=131, Expect=9e-34]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=66.2, Expect=3e-11]} {Celegans: WBGene00012124, T28D6.4, [Score=62.8, Expect=3e-10]} {Smed: dd_Smed_v6_11187_0_3, dd_Smed_v6_11187_0_3, [Score=56.6, Expect=2e-08]} {RNA815_38023} |
66. | MligTC455_19212 | 100 | 2.09 | Mlig455_053588 | Neo: - Age: - |
1.88 | 0.952 | - | - | - | - | 0.928 | Mlig455_053588 {REF} {Length: 1342} {Celegans: WBGene00019180, H10D18.5, [RH, Score=62.8, Expect=5e-11]} {Smed: dd_Smed_v6_10251_0_1, dd_Smed_v6_10251_0_1, [RH, Score=95.5, Expect=3e-23]} {RNA1310_25906} {RNA815_14581.1} | |
67. | MligTC455_36826 | 28 | 0.58 | Mlig455_013198 | Neo: - Age: - Region-enriched R2: 5.359/0.01396 |
HSPB6 | 1.877 | 0.974 | - | 0.903 | - | - | - | Mlig455_013198 {REF} {Length: 2372} {Pfam: Hsp20/alpha crystallin family [PF00011.23, score=56.3]} {Human: ENSG00000004776, HSPB6, heat shock protein family B (small) member 6, [RH, Score=55.5, Expect=8e-09]} {Mouse: ENSMUSG00000036854, Hspb6, heat shock protein, alpha-crystallin-related, B6, [RH, Score=58.5, Expect=7e-10]} {Dmel: FBgn0011296, l(2)efl, lethal (2) essential for life, [Score=57.8, Expect=1e-09]} {Smed: dd_Smed_v6_15128_0_1, dd_Smed_v6_15128_0_1, [RH, Score=81.3, Expect=3e-17]} {RNA1310_41920} {RNA815_42079} |
68. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
1.873 | - | - | 0.911 | - | 0.962 | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
69. | MligTC455_26200 | 12 | 0.26 | Mlig455_068734 | Neo: - Age: - |
TNXB | 1.872 | - | - | 0.974 | - | 0.898 | - | Mlig455_068734 {REF} {Length: 1237} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=176.4]} {Human: ENSG00000229353, TNXB, tenascin XB, [RH, Score=133, Expect=3e-34]; ENSG00000236236, TNXB, tenascin XB, [RH, Score=132, Expect=6e-34]; ENSG00000168477, TNXB, tenascin XB, [RH, Score=132, Expect=6e-34]} {Mouse: ENSMUSG00000033327, Tnxb, tenascin XB, [Score=131, Expect=8e-34]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=129, Expect=5e-34]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=128, Expect=1e-33]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=127, Expect=5e-33]} {Dmel: FBgn0033312, CG8642, [Score=110, Expect=2e-27]} {Celegans: WBGene00020516, T15B7.1, [Score=61.6, Expect=1e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=113, Expect=4e-28]} {RNA1310_44670.1} {RNA815_23388} |
70. | MligTC455_40905 | 53 | 1.1 | Mlig455_002794, Mlig455_002809 | Neo: - Age: - |
CHL1 | 1.872 | - | - | 0.977 | - | 0.895 | - | Mlig455_002794 {REF} {Length: 4845} {Pfam: Immunoglobulin domain [PF13927.8, score=205.6]; Immunoglobulin I-set domain [PF07679.18, score=151.2]; Immunoglobulin domain [PF00047.27, score=122.8]; Immunoglobulin domain [PF13895.8, score=109.6]; Fibronectin type III domain [PF00041.23, score=98.8]; Immunoglobulin V-set domain [PF07686.19, score=65.4]; Immunoglobulin domain [PF18452.3, score=21.7]} {Human: ENSG00000134121, CHL1, cell adhesion molecule L1 like, [RH, Score=340, Expect=1e-96]} {Mouse: ENSMUSG00000031391, L1cam, L1 cell adhesion molecule, [RH, Score=339, Expect=2e-96]; ENSMUSG00000030077, Chl1, cell adhesion molecule L1-like, [RH, Score=335, Expect=4e-95]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=358, Expect=2e-103]} {Celegans: WBGene00002243, lad-2, Immunoglobulin domain-containing protein Y54G2A.25; L1 CAM ADhesion molecule homolog; LAD-2 long isoform, [Score=287, Expect=1e-79]} {Smed: dd_Smed_v6_1916_0_1, dd_Smed_v6_1916_0_1, [Score=486, Expect=3e-148]} {RNA1310_42673} Mlig455_002809 {REF} {Length: 4785} {Pfam: Immunoglobulin domain [PF13927.8, score=155.8]; Immunoglobulin I-set domain [PF07679.18, score=111.7]; Fibronectin type III domain [PF00041.23, score=99.0]; Immunoglobulin domain [PF00047.27, score=90.9]; Immunoglobulin domain [PF13895.8, score=77.2]; Immunoglobulin V-set domain [PF07686.19, score=38.0]} {Human: ENSG00000134121, CHL1, cell adhesion molecule L1 like, [Score=292, Expect=8e-81]; ENSG00000163531, NFASC, neurofascin, [Score=290, Expect=4e-80]} {Mouse: ENSMUSG00000031391, L1cam, L1 cell adhesion molecule, [Score=294, Expect=2e-81]; ENSMUSG00000026442, Nfasc, neurofascin, [Score=290, Expect=2e-80]; ENSMUSG00000030077, Chl1, cell adhesion molecule L1-like, [Score=285, Expect=2e-78]; ENSMUSG00000020598, Nrcam, neuronal cell adhesion molecule, [Score=282, Expect=7e-78]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=315, Expect=1e-88]} {Celegans: WBGene00002243, lad-2, Immunoglobulin domain-containing protein Y54G2A.25; L1 CAM ADhesion molecule homolog; LAD-2 long isoform, [Score=251, Expect=9e-68]} {Smed: dd_Smed_v6_1916_0_1, dd_Smed_v6_1916_0_1, [Score=441, Expect=4e-132]} {RNA1310_42673} |
71. | MligTC455_05183 | 13 | 0.27 | Mlig455_003637 | Neo: - Age: - |
1.871 | - | - | 0.973 | - | 0.898 | - | Mlig455_003637 {REF} {Length: 906} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [Score=57.0, Expect=8e-10]} {RNA1310_45613} {RNA815_17816.1} | |
72. | MligTC455_38910 | 47 | 0.98 | Mlig455_010417 | Neo: - Age: Up-Down-Down |
TRIM56 | 1.87 | 0.967 | - | 0.903 | - | - | - | Mlig455_010417 {REF} {Length: 4419} {Pfam: RING-type zinc-finger [PF13445.8, score=28.8]; Ring finger domain [PF13639.8, score=24.5]; zinc finger of C3HC4-type, RING [PF15227.8, score=23.6]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.0]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=22.0]; Prokaryotic RING finger family 4 [PF14447.8, score=21.2]} {Human: ENSG00000169871, TRIM56, tripartite motif containing 56, [Score=53.9, Expect=8e-07]} {Celegans: WBGene00003599, nhl-3, NHL (Ring finger b-box coiled coil) domain containing, [Score=48.5, Expect=1e-05]} {Smed: dd_Smed_v6_2039_0_1, dd_Smed_v6_2039_0_1, [RH, Score=197, Expect=9e-56]} {RNA1509_36668} {RNA1310_41319, RNA1509_36668} {RNA1509_36668, RNA815_52219} |
73. | MligTC455_15183 | 10 | 0.2 | Mlig455_018461 | Neo: - Age: Down-Up-Down |
SCNN1A | 1.869 | - | - | 0.978 | - | 0.891 | - | Mlig455_018461 {REF} {Length: 2620} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.7]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=67.8, Expect=4e-11]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=55.5, Expect=6e-08]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.9, Expect=5e-12]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} |
74. | MligTC455_44725 | 67 | 1.4 | Mlig455_024194 | Neo: - Age: - |
1.867 | - | - | 0.975 | - | 0.892 | - | Mlig455_024194 {REF} {Length: 956} {RNA1310_84543} {RNA815_47586} | |
75. | MligTC455_12867 | 14 | 0.29 | Mlig455_049571 | Neo: - Age: - |
KCNIP3 | 1.865 | - | - | 0.960 | - | 0.905 | - | Mlig455_049571 {REF} {Length: 1857} {Pfam: EF-hand domain pair [PF13499.8, score=50.8]; EF hand [PF00036.34, score=44.5]; EF-hand domain [PF13405.8, score=39.6]; EF-hand domain pair [PF13833.8, score=32.7]; EF hand [PF13202.8, score=30.8]} {Human: ENSG00000115041, KCNIP3, potassium voltage-gated channel interacting protein 3, [Score=155, Expect=4e-44]; ENSG00000120049, KCNIP2, potassium voltage-gated channel interacting protein 2, [Score=148, Expect=1e-41]} {Mouse: ENSMUSG00000025221, Kcnip2, Kv channel-interacting protein 2, [Score=146, Expect=4e-41]; ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=140, Expect=7e-39]} {Dmel: FBgn0265595, CG44422, [Score=154, Expect=3e-42]} {Celegans: WBGene00003563, ncs-1, Neuronal calcium sensor 1, [Score=125, Expect=1e-33]} {Smed: dd_Smed_v6_9434_0_1, dd_Smed_v6_9434_0_1, [Score=127, Expect=2e-34]} {RNA1310_70106} {RNA815_36691} |
76. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
1.862 | - | - | 0.961 | - | 0.901 | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
77. | MligTC455_44954 | 1303 | 27.14 | Mlig455_029595, Mlig455_070648 | Neo: Int S/G2/M Age: Down-Up-Up, logFC(26M/2M)=1.023 Region-specific R2: 8.846 Region-enriched R2: 10.764/0.00000 |
1.862 | - | - | 0.962 | - | 0.900 | - | Mlig455_029595 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871} {RNA1310_66833.2} {RNA815_41767} Mlig455_070648 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871, RNA1509_39484} {RNA1310_66833.2, RNA1509_20871, RNA1509_39484} {RNA1509_20871, RNA1509_39484, RNA815_41767} |
|
78. | MligTC455_22742 | 66 | 1.38 | Mlig455_010648 | Neo: - Age: - |
ERBIN | 1.861 | 0.962 | - | - | - | - | 0.899 | Mlig455_010648 {REF} {Length: 1753} {Pfam: Leucine Rich repeats (2 copies) [PF12799.9, score=99.0]; Leucine rich repeat [PF13855.8, score=69.5]; Leucine Rich repeat [PF13516.8, score=20.6]; Leucine-rich repeat [PF14580.8, score=19.8]} {Human: ENSG00000112851, ERBIN, erbb2 interacting protein, [Score=76.6, Expect=6e-14]; ENSG00000139263, LRIG3, leucine rich repeats and immunoglobulin like domains 3, [Score=72.8, Expect=9e-13]} {Mouse: ENSMUSG00000040367, Lrrd1, leucine rich repeats and death domain containing 1, [Score=87.8, Expect=1e-17]} {Dmel: FBgn0263289, scrib, scribbled, [Score=74.7, Expect=1e-13]} {Celegans: WBGene00006593, tol-1, TOLl (Drosophila) family, [Score=68.6, Expect=7e-12]} {Smed: dd_Smed_v6_5405_0_1, dd_Smed_v6_5405_0_1, [Score=70.9, Expect=2e-13]} {RNA1509_53260} {RNA1310_7797} {RNA815_29209} |
79. | MligTC455_44159 | 80 | 1.67 | Mlig455_019040, Mlig455_055663 | Neo: - Age: Down-Up-Up |
ADRB1, GALR3 | 1.861 | - | - | 0.969 | - | 0.892 | - | Mlig455_019040 {REF} {Length: 1804} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=31.3]} {Human: ENSG00000043591, ADRB1, adrenoceptor beta 1, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=47.8, Expect=1e-05]} {Dmel: FBgn0038874, ETHR, [Score=49.3, Expect=3e-06]} {Celegans: WBGene00017661, frpr-6, FMRFamide Peptide Receptor family, [Score=54.3, Expect=5e-08]} {Smed: dd_Smed_v6_19933_0_1, dd_Smed_v6_19933_0_1, [RH, Score=124, Expect=9e-33]} {RNA1310_47955} {RNA815_45615} Mlig455_055663 {REF} {Length: 1667} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.2]} {Human: ENSG00000128310, GALR3, galanin receptor 3, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [Score=103, Expect=6e-25]} {RNA1310_86586} {RNA815_45615} |
80. | MligTC455_18955 | 13 | 0.27 | Mlig455_047126 | Neo: - Age: - |
1.86 | - | - | 0.978 | - | 0.882 | - | Mlig455_047126 {REF} {Length: 1058} | |
81. | MligTC455_48692 | 15 | 0.32 | Mlig455_021398 | Neo: - Age: - Region-enriched R2: 8.096/0.02429 |
1.86 | - | - | 0.965 | - | 0.895 | - | Mlig455_021398 {REF} {Length: 1571} {Pfam: Ankyrin repeat [PF00023.32, score=20.9]; Ankyrin repeats (many copies) [PF13637.8, score=20.4]; Ankyrin repeats (many copies) [PF13857.8, score=19.6]; Ankyrin repeats (3 copies) [PF12796.9, score=19.4]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=54.7, Expect=3e-08]} {RNA1310_69005} | |
82. | MligTC455_19551 | 361 | 7.52 | Mlig455_047808, Mlig455_047885 | Neo: - Age: - |
1.859 | 0.983 | - | - | - | - | 0.876 | Mlig455_047808 {REF} {Length: 3001} {Smed: dd_Smed_v6_14814_0_1, dd_Smed_v6_14814_0_1, [Score=88.2, Expect=2e-22]} {RNA1509_46635} {RNA1310_30981} {RNA815_12742} Mlig455_047885 {REF} {Length: 1622} {Smed: dd_Smed_v6_14814_0_1, dd_Smed_v6_14814_0_1, [Score=88.2, Expect=2e-22]} {RNA1509_40551} {RNA1310_30981} {RNA815_12742} |
|
83. | MligTC455_16606 | 108 | 2.26 | Mlig455_034973, Mlig455_053711, Mlig455_060000 | Neo: - Age: - Region-enriched R2: 5.697/0.00617 |
GLRA2 | 1.858 | - | - | 0.982 | - | 0.876 | - | Mlig455_034973 {REF} {Length: 1000} {RNA1310_100434} Mlig455_053711 {REF} {Length: 2327} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=60.8, Expect=3e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=61.6, Expect=1e-09]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=60.5, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1310_56609} {RNA815_37711} Mlig455_060000 {REF} {Length: 2781} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=62.0, Expect=1e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=62.0, Expect=7e-10]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=62.0, Expect=7e-10]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=5e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1509_50322} {RNA1310_56609} {RNA815_37711} |
84. | MligTC455_28720 | 27 | 0.56 | Mlig455_057010 | Neo: - Age: - |
ASIC1 | 1.858 | - | - | 0.962 | - | 0.896 | - | Mlig455_057010 {REF} {Length: 2468} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=174.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=62.4, Expect=1e-09]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016063, delm-2, DEgenerin Linked to Mechanosensation, [Score=53.1, Expect=3e-07]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=109, Expect=2e-25]} {RNA1310_71846} {RNA815_38264} |
85. | MligTC455_15332 | 44 | 0.93 | Mlig455_062622, Mlig455_067527 | Neo: - Age: - Region-enriched R2: 7.516/0.00418 |
ASIC4 | 1.857 | - | - | 0.969 | - | 0.888 | - | Mlig455_062622 {REF} {Length: 2228} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=73.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=47.4, Expect=7e-06]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=51.6, Expect=2e-07]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=55.8, Expect=3e-09]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.1, Expect=2e-08]} {RNA1310_17847} {RNA815_27317} Mlig455_067527 {REF} {Length: 1916} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=147.3]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=50.1, Expect=1e-05]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=50.8, Expect=3e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.5, Expect=2e-07]} {RNA1310_17847} {RNA815_27317} |
86. | MligTC455_29264 | 78 | 1.62 | Mlig455_061707 | Neo: - Age: logFC(26M/2M)=1.238 |
1.857 | - | - | 0.971 | - | 0.886 | - | Mlig455_061707 {REF} {Length: 5671} {Pfam: Zinc knuckle [PF00098.25, score=33.9]} {Celegans: WBGene00017210, F07E5.5, [Score=53.5, Expect=3e-07]} {RNA1509_12781} {RNA1310_541.1} {RNA815_23.1} | |
87. | MligTC455_43524 | 172 | 3.58 | Mlig455_031179 | Neo: - Age: - Region-enriched R2: 3.416/0.00534 |
SLC30A2 | 1.856 | 0.959 | - | - | - | 0.897 | - | Mlig455_031179 {REF} {Length: 2311} {Pfam: Cation efflux family [PF01545.23, score=155.3]; Dimerisation domain of Zinc Transporter [PF16916.7, score=21.1]} {Human: ENSG00000158014, SLC30A2, solute carrier family 30 member 2, [Score=350, Expect=3e-117]} {Mouse: ENSMUSG00000028836, Slc30a2, solute carrier family 30 (zinc transporter), member 2, [Score=362, Expect=3e-122]} {Dmel: FBgn0028516, ZnT35C, Zinc transporter 35C, [RH, Score=324, Expect=1e-106]} {Celegans: WBGene00011821, cdf-2, Cation Diffusion Facilitator family, [RH, Score=324, Expect=7e-108]} {Smed: dd_Smed_v6_5529_0_1, dd_Smed_v6_5529_0_1, [Score=432, Expect=4e-150]} {RNA1509_37229} {RNA1310_13324.1} {RNA815_5520} |
88. | MligTC455_07555 | 12 | 0.26 | Mlig455_028021 | Neo: - Age: - |
1.855 | - | - | 0.964 | - | 0.891 | - | Mlig455_028021 {REF} {Length: 1905} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.9]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=58.2, Expect=1e-08]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [RH, Score=182, Expect=2e-52]} | |
89. | MligTC455_14172 | 11 | 0.22 | Mlig455_042536 | Neo: - Age: - |
STON2 | 1.854 | - | - | 0.974 | - | 0.880 | - | Mlig455_042536 {REF} {Length: 4650} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=54.1]} {Human: ENSG00000140022, STON2, stonin 2, [Score=131, Expect=3e-30]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [Score=132, Expect=1e-30]} {Dmel: FBgn0016975, stnB, stoned B, [Score=142, Expect=6e-34]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [Score=155, Expect=6e-38]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [Score=221, Expect=2e-58]} {RNA1310_91122} |
90. | MligTC455_16476 | 126 | 2.63 | Mlig455_042936 | Neo: - Age: - Region-enriched R2: 3.045/0.04509 |
1.853 | - | - | - | - | 0.956 | 0.897 | Mlig455_042936 {REF} {Length: 2571} {Pfam: Innexin [PF00876.20, score=347.0]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=102, Expect=9e-24]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=280, Expect=3e-91]} {Smed: dd_Smed_v6_10567_0_1, dd_Smed_v6_10567_0_1, [RH, Score=498, Expect=8e-177]} {RNA1509_13614} {RNA1310_14284} {RNA815_5221} | |
91. | MligTC455_00067 | 6 | 0.13 | Mlig455_035302 | Neo: - Age: - |
1.85 | - | - | 0.978 | - | 0.872 | - | Mlig455_035302 {REF} {Length: 1437} | |
92. | MligTC455_50778 | 36 | 0.76 | Mlig455_042296 | Neo: - Age: - |
GPR50 | 1.849 | - | - | 0.968 | - | 0.881 | - | Mlig455_042296 {REF} {Length: 1415} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=116.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=40.0]; Olfactory receptor [PF13853.8, score=34.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=33.9]} {Human: ENSG00000102195, GPR50, G protein-coupled receptor 50, [Score=124, Expect=4e-31]; ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=119, Expect=2e-30]} {Mouse: ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=120, Expect=4e-31]; ENSMUSG00000056380, Gpr50, G-protein-coupled receptor 50, [Score=119, Expect=2e-29]; ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=118, Expect=5e-30]} {Dmel: FBgn0038980, Octbeta1R, Octopamine beta1 receptor, [Score=92.0, Expect=1e-20]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=69.7, Expect=4e-13]} {Smed: dd_Smed_v6_65999_0_1, dd_Smed_v6_65999_0_1, [Score=84.7, Expect=1e-18]} {RNA1310_66047} {RNA815_34066} |
93. | MligTC455_27918 | 42 | 0.87 | Mlig455_004025, Mlig455_004105, Mlig455_039294 | Neo: - Age: Down-Up-Up |
1.848 | - | - | 0.976 | - | 0.872 | - | Mlig455_004025 {REF} {Length: 2650} {RNA1310_16141} {RNA815_7007} Mlig455_004105 {REF} {Length: 1268} {RNA1310_85247} {RNA815_59251} Mlig455_039294 {REF} {Length: 2639} {RNA1310_16141} {RNA815_7007} |
|
94. | MligTC455_36194 | 30 | 0.61 | Mlig455_064360, Mlig455_064382 | Neo: - Age: - |
B3GNT4 | 1.848 | - | - | 0.969 | - | 0.879 | - | Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
95. | MligTC455_13007 | 32 | 0.67 | Mlig455_055548 | Neo: - Age: - |
PCDH11Y | 1.847 | 0.960 | - | - | - | 0.887 | - | Mlig455_055548 {REF} {Length: 4787} {Pfam: Cadherin domain [PF00028.19, score=284.6]; Cadherin-like [PF08266.14, score=46.3]; Cadherin-like [PF16184.7, score=42.7]; Cadherin prodomain like [PF08758.13, score=32.3]} {Human: ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=294, Expect=8e-84]; ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=294, Expect=1e-83]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=282, Expect=8e-80]} {Dmel: FBgn0001075, ft, fat, [Score=239, Expect=2e-64]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=202, Expect=1e-52]} {Smed: dd_Smed_v6_18373_0_1, dd_Smed_v6_18373_0_1, [Score=295, Expect=4e-84]} {RNA1509_54067} {RNA1310_21501} {RNA815_32416} |
96. | MligTC455_17286 | 18 | 0.37 | Mlig455_062850, Mlig455_062932 | Neo: - Age: - |
NPFFR2, QRFPR | 1.846 | - | - | 0.974 | - | 0.872 | - | Mlig455_062850 {REF} {Length: 2774} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=136.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=17.9]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=132, Expect=1e-33]; ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=130, Expect=4e-33]} {Mouse: ENSMUSG00000031212, Pgr15l, G protein-coupled receptor 15-like, [Score=137, Expect=9e-36]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=138, Expect=9e-36]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=95.1, Expect=4e-21]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=105, Expect=1e-24]} {RNA1310_125205} Mlig455_062932 {REF} {Length: 1463} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=135.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=19.2]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=129, Expect=7e-33]; ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=128, Expect=2e-32]} {Mouse: ENSMUSG00000031212, Pgr15l, G protein-coupled receptor 15-like, [Score=138, Expect=8e-36]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=136, Expect=4e-35]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=95.1, Expect=4e-21]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=105, Expect=1e-24]} {RNA1310_125205} |
97. | MligTC455_50777 | 40 | 0.83 | Mlig455_042072 | Neo: - Age: - |
MTNR1B | 1.845 | - | - | 0.960 | - | 0.885 | - | Mlig455_042072 {REF} {Length: 2881} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.0]; Olfactory receptor [PF13853.8, score=24.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]} {Human: ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=94.4, Expect=2e-21]; ENSG00000168412, MTNR1A, melatonin receptor 1A, [Score=90.1, Expect=5e-20]} {Mouse: ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=94.0, Expect=2e-21]; ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=89.4, Expect=6e-20]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=57.0, Expect=7e-09]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_19535_0_1, dd_Smed_v6_19535_0_1, [Score=95.5, Expect=2e-22]} {RNA1310_66047} {RNA815_34066} |
98. | MligTC455_27304 | 420 | 8.75 | Mlig455_027275 | Neo: - Age: Down-Up-Down Region-enriched R2: 1.861/0.02823 |
1.844 | 0.965 | - | 0.879 | - | - | - | Mlig455_027275 {REF} {Length: 2821} {Pfam: Cupin-like domain [PF13621.8, score=94.1]; Cupin superfamily protein [PF08007.14, score=22.4]} {Mouse: ENSMUSG00000030752, Kdm8, lysine (K)-specific demethylase 8, [Score=59.7, Expect=3e-09]} {Dmel: FBgn0035166, CG13902, [Score=59.7, Expect=2e-09]} {Celegans: WBGene00007387, jmjd-5, JuMonJi (Transcription factor) Domain protein, [Score=55.5, Expect=5e-08]} {Smed: dd_Smed_v6_14490_0_1, dd_Smed_v6_14490_0_1, [RH, Score=349, Expect=5e-117]} {RNA1509_20375} {RNA1310_22474} {RNA815_8659} | |
99. | MligTC455_52544 | 250 | 5.21 | Mlig455_030562 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.544/0.00108 |
1.844 | 0.973 | - | - | - | - | 0.871 | Mlig455_030562 {REF} {Length: 1251} {RNA1310_32103} {RNA815_22028} | |
100. | MligTC455_50602 | 84 | 1.74 | Mlig455_065088 | Neo: - Age: - |
1.843 | - | - | 0.968 | - | 0.875 | - | Mlig455_065088 {REF} {Length: 2765} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=129.5]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=67.8, Expect=6e-12]} {RNA1310_8235} {RNA815_10456.1} |